Molecure S.A. (MOC.WA)

PLN 8.5

(5.72%)

Total Debt Summary of Molecure S.A.

Molecure S.A.'s latest annual total debt in 2023 was 7.13 Million PLN , up 11.41% from previous year.
Molecure S.A.'s latest quarterly total debt in 2024 Q3 was 1.61 Million PLN , down -8.39% from previous quarter.
Molecure S.A. reported annual total debt of 6.4 Million PLN in 2022, up 6.64% from previous year.
Molecure S.A. reported annual total debt of 6 Million PLN in 2021, up 14.9% from previous year.
Molecure S.A. reported quarterly total debt of 6.07 Million PLN for 2024 Q2, down -8.25% from previous quarter.
Molecure S.A. reported quarterly total debt of 1.61 Million PLN for 2024 Q3, down -8.39% from previous quarter.

Annual Total Debt Chart of Molecure S.A. (2023 - 2014)

Historical Annual Total Debt of Molecure S.A. (2023 - 2014)

Year	Total Debt	Total Debt Growth
2023	7.13 Million PLN	11.41%
2022	6.4 Million PLN	6.64%
2021	6 Million PLN	14.9%
2020	5.22 Million PLN	36.7%
2019	3.82 Million PLN	0.0%
2018	- PLN	0.0%
2017	- PLN	0.0%
2016	- PLN	0.0%
2015	- PLN	0.0%
2014	- PLN	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	6.61 Million PLN	-7.3%
2024 Q2	6.07 Million PLN	-8.25%
2024 Q3	1.61 Million PLN	-8.39%
2023 Q2	5.25 Million PLN	-10.05%
2023 Q3	4.68 Million PLN	-10.92%
2023 Q4	7.13 Million PLN	52.41%
2023 FY	7.13 Million PLN	11.41%
2023 Q1	5.84 Million PLN	-8.77%
2022 Q3	5.21 Million PLN	0.82%
2022 Q2	5.17 Million PLN	-6.57%
2022 FY	6.4 Million PLN	6.64%
2022 Q1	5.53 Million PLN	-7.85%
2022 Q4	6.4 Million PLN	22.86%
2021 Q4	6 Million PLN	-3.21%
2021 Q3	6.2 Million PLN	-7.29%
2021 Q2	6.69 Million PLN	37.84%
2021 FY	6 Million PLN	14.9%
2021 Q1	4.85 Million PLN	-7.11%
2020 Q1	3.52 Million PLN	-7.76%
2020 Q2	3.21 Million PLN	-8.81%
2020 FY	5.22 Million PLN	36.7%
2020 Q4	5.22 Million PLN	81.05%
2020 Q3	2.88 Million PLN	-10.23%
2019 Q4	3.82 Million PLN	52.29%
2019 FY	3.82 Million PLN	0.0%
2019 Q3	2.51 Million PLN	-10.43%
2019 Q2	2.8 Million PLN	-7.61%
2019 Q1	3.03 Million PLN	0.0%
2018 Q4	- PLN	0.0%
2018 FY	- PLN	0.0%
2018 Q1	- PLN	0.0%
2018 Q2	- PLN	0.0%
2018 Q3	- PLN	0.0%
2017 Q2	- PLN	0.0%
2017 FY	- PLN	0.0%
2017 Q3	- PLN	0.0%
2017 Q4	- PLN	0.0%
2017 Q1	- PLN	0.0%
2016 Q4	- PLN	0.0%
2016 FY	- PLN	0.0%
2016 Q1	- PLN	0.0%
2015 FY	- PLN	0.0%
2014 FY	- PLN	0.0%

Peer Total Debt Comparison of Molecure S.A.

Name	Total Debt	Total Debt Difference
Bioceltix S.A.	175.05 Thousand PLN	-3978.325%
BIOTON S.A.	68.69 Million PLN	89.607%
Captor Therapeutics Spolka Akcyjna	3.77 Million PLN	-88.973%
Mabion S.A.	35.82 Million PLN	80.073%
NanoGroup S.A.	- PLN	-Infinity%
Pharmena S.A.	181 Thousand PLN	-3844.416%
Poltreg S.A.	8.19 Million PLN	12.87%
Pure Biologics Spólka Akcyjna	12.93 Million PLN	44.818%
Ryvu Therapeutics S.A.	906 Thousand PLN	-688.012%
Synthaverse S.A.	70.04 Million PLN	89.807%
Urteste S.A.	627 Thousand PLN	-1038.659%